Home › Funds › TANG CAPITAL MANAGEMENT LLC › MIRM
TANG CAPITAL MANAGEMENT LLC position in MIRM
MIRUM PHARMACEUTICALS INC · Health Care
TANG CAPITAL MANAGEMENT LLC reported holding 1,236,027 shares of MIRM (MIRUM PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$144.7M, representing 6.57% of its reported portfolio and ranking #3 among its reported holdings. TANG CAPITAL MANAGEMENT LLC has disclosed MIRM holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How TANG CAPITAL MANAGEMENT LLC's MIRM position evolved
TANG CAPITAL MANAGEMENT LLC first disclosed a stake in MIRM in Q3 2023 at 1,137,107 shares (US$35.9M). The position peaked in Q2 2026 at 1,236,027 shares, worth US$144.7M. Across 12 filings, TANG CAPITAL MANAGEMENT LLC increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 7 time(s). The most recent filing (Q2 2026) shows 1,236,027 shares valued at US$144.7M. Notable position changes include a 79% increase in Q2 2024 (shares rose 14% over the following quarter), a 39% trim in Q3 2024 (shares rose 6% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 1.14M | $35.93M | New |
| Q4 2023 | 1.14M | $33.57M | Hold |
| Q1 2024 | 1.19M | $29.82M | Add |
| Q2 2024 | 2.12M | $2.83M | Add |
| Q3 2024 | 1.29M | $50.20M | Reduce |
| Q4 2024 | 1.24M | $51.15M | Reduce |
| Q1 2025 | 1.24M | $55.73M | Hold |
| Q2 2025 | 1.24M | $62.90M | Hold |
| Q3 2025 | 1.24M | $90.61M | Hold |
| Q4 2025 | 1.24M | $97.63M | Hold |
| Q1 2026 | 1.24M | $114.18M | Hold |
| Q2 2026 | 1.24M | $144.70M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MIRM and 13F data
MIRM (MIRUM PHARMACEUTICALS INC) is a Health Care company. 61 other funds we track also report a position in MIRM — the largest reported positions include Frazier Life Sciences Management, L.P. (US$899.1M), EVENTIDE ASSET MANAGEMENT, LLC (US$146.2M), Novo Holdings A/S (US$131.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MIRM
- Frazier Life Sciences Management, L.P. 7.68M sh · $899.06M · Q2 2026
- EVENTIDE ASSET MANAGEMENT, LLC 1.25M sh · $146.20M · Q2 2026
- Novo Holdings A/S 1.12M sh · $131.70M · Q2 2026
- TCG Crossover Management, LLC 1.06M sh · $124.33M · Q2 2026
- BVF INC/IL 1.06M sh · $123.63M · Q2 2026
- Rock Springs Capital Management LP 798.14K sh · $93.44M · Q2 2026
- TENOR CAPITAL MANAGEMENT Co., L.P. 24.65M sh · $91.66M · Q2 2026
- CAPSTONE INVESTMENT ADVISORS, LLC 18.45M sh · $68.30M · Q2 2026
- EMERALD ADVISERS, LLC 468.30K sh · $54.82M · Q2 2026
- BAKER BROS. ADVISORS LP 445.98K sh · $52.21M · Q2 2026
- NEXT CENTURY GROWTH INVESTORS LLC 420.21K sh · $49.19M · Q2 2026
- BOONE CAPITAL MANAGEMENT LLC 415.64K sh · $48.66M · Q2 2026
More on TANG CAPITAL MANAGEMENT LLC
FAQ
How long has TANG CAPITAL MANAGEMENT LLC held MIRM?
TANG CAPITAL MANAGEMENT LLC has disclosed MIRM holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is TANG CAPITAL MANAGEMENT LLC's current position in MIRM?
As of Q2 2026, TANG CAPITAL MANAGEMENT LLC holds 1.24M shares of MIRM (MIRUM PHARMACEUTICALS INC), valued at $144.70M, representing 6.57% of its reported portfolio and ranking #3.
Has TANG CAPITAL MANAGEMENT LLC been buying or selling MIRM?
In the latest 13F filing (Q2 2026), TANG CAPITAL MANAGEMENT LLC held unchanged its position in MIRM. The position peaked in Q2 2026 at 1.24M shares.
Which other funds hold MIRM?
Other major institutional holders of MIRM include Frazier Life Sciences Management, L.P., EVENTIDE ASSET MANAGEMENT, LLC, Novo Holdings A/S, among 61 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.